AMSBIO: Transfecting Human Embryonic Stem Cells

Hits:768   Date: 11/20/2019

AMSBIO reports on how it has worked with Singapore General Hospital (Singapore) to help them identify the best reagent to transfect their human embryonic stems cells.

Historically the research group of Prof Tan Eng-King had used GeneIN, a transfection reagent specifically developed for stem cells which is now no longer available. Working with AMSBIO, Singapore General Hospital tested several reagents before electing to switch to GenePORTER® 2 to efficiently transfect their human embryonic stem cells. Senior researcher - Dr Christine Chan Hui Shan commented “Human embryonic stem cells are notoriously difficult-to-transfect primary cells. GenePORTER 2 enabled us to deliver our target genes into hESCs with an improved efficiency, compared to some other commercially available transfection reagents."

GenePORTER® 2 transfection reagent is a proprietary lipid formulation specifically designed to provide high transfection efficiencies in a broad range of mammalian cells. GenePORTER® 2 is especially effective in difficult-to-transfect cells, such as PC-12, macrophages, and primary cells. Developed using a high-throughput transfection assay that screens a large library of cationic lipids, the GenePORTER® 2 reagent was selected based on high transfection efficiency, low cytotoxicity, and exceptional stability. Additionally, because of its minimized interaction with serum components, the GenePORTER® 2 transfection reagent is ideal for transfection in serum containing media.

AMSBIO aims to help advance stem cell discovery by supplying research scientists with the necessary tools and reagents needed to work more efficiently and obtain reliable results faster. Stem cells, particularly human embryonic stem cells, are a notoriously labile cell type. Without careful attention, these cells tend to spontaneously differentiate and undergo genomic rearrangements in culture. Today, AMSBIO is able to offer researchers an unmatched range of high-performance stem-cell-optimized and -qualified growth media, sera, feeder cells, supplements, growth factors and assay kits.

For further information about GenePORTER® 2 transfection reagent please visit http://www.amsbio.com/geneporter2-transfection-reagent.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. 

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.

---------------------

Worldwide HQ 

AMS Biotechnology (AMSBIO)

184 Milton Park
Abingdon

Oxon OX14 4SE

UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com   
Web www.amsbio.com

 

North American HQ
 

AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033 
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web www.amsbio.com